SE388420B - Sett att framstella cyklopropylmetylaminderivat - Google Patents

Sett att framstella cyklopropylmetylaminderivat

Info

Publication number
SE388420B
SE388420B SE7317257A SE7317257A SE388420B SE 388420 B SE388420 B SE 388420B SE 7317257 A SE7317257 A SE 7317257A SE 7317257 A SE7317257 A SE 7317257A SE 388420 B SE388420 B SE 388420B
Authority
SE
Sweden
Prior art keywords
preparing
cyclopropylmethylamine
derivatives
cyclopropylmethylamine derivatives
preparing cyclopropylmethylamine
Prior art date
Application number
SE7317257A
Other languages
English (en)
Swedish (sv)
Inventor
C Malen
M Desnos
M Laubie
J-C Poignant
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of SE388420B publication Critical patent/SE388420B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/06—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms
    • C07C335/08—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/04—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms
    • C07C275/18—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/06—1,3-Oxazines; Hydrogenated 1,3-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
SE7317257A 1972-12-28 1973-12-20 Sett att framstella cyklopropylmetylaminderivat SE388420B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5988672A GB1453703A (en) 1972-12-28 1972-12-28 Substituted cyclopropylmethylamines processes for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SE388420B true SE388420B (sv) 1976-10-04

Family

ID=10484588

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7317257A SE388420B (sv) 1972-12-28 1973-12-20 Sett att framstella cyklopropylmetylaminderivat

Country Status (20)

Country Link
US (1) US3988464A (de)
JP (3) JPS5335949B2 (de)
AR (2) AR207336A1 (de)
AT (1) AT333272B (de)
BE (1) BE809179A (de)
CH (2) CH592641A5 (de)
CS (1) CS186258B2 (de)
DD (1) DD110869A5 (de)
DE (1) DE2362754C2 (de)
DK (1) DK145574C (de)
ES (1) ES421879A1 (de)
FI (1) FI59999C (de)
FR (1) FR2212143B1 (de)
GB (1) GB1453703A (de)
HU (1) HU169273B (de)
IL (3) IL49288A (de)
NL (1) NL169472C (de)
SE (1) SE388420B (de)
SU (2) SU505348A3 (de)
ZA (1) ZA739694B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2358890A1 (fr) * 1976-05-24 1978-02-17 Science Union & Cie Nouvelles aryl trifluoroethylamines, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2432513A1 (fr) * 1977-10-24 1980-02-29 Merieux Inst Nouveaux derives de la thiazoline et leur application comme medicaments
DE2831600A1 (de) * 1978-07-19 1980-01-31 Boehringer Sohn Ingelheim Neue substituierte 2-phenylamino-1, 3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben
FR2444673A1 (fr) * 1978-12-20 1980-07-18 Science Union & Cie Nouvelles trifluoroethylamines, leurs procedes d'obtention et leur emploi comme medicament
FR2669927B1 (fr) * 1990-11-29 1994-04-08 Adir Cie Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE19716237A1 (de) * 1997-04-18 1998-10-22 Basf Ag Substituierte Benzyloxyimino-Verbindungen
AUPP020297A0 (en) * 1997-11-05 1997-11-27 University Of Melbourne, The A novel receptor, and compounds which bind thereto
EP1517688A2 (de) 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
US20060283363A1 (en) * 2005-06-07 2006-12-21 Wollman Albert E Potato Planter Improvement to Reduce Skips and Rolling
KR20160042039A (ko) 2013-08-09 2016-04-18 알데릭스, 인코포레이티드 인산염 수송을 억제하기 위한 화합물 및 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626067A (en) * 1965-07-01 1971-12-07 Du Pont Substituted oxazolines, useful as pharmaceuticals
NL128801C (de) * 1965-11-19
DE1670751A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-2-oxazolinen
DE1670753A1 (de) * 1966-09-27 1970-07-16 Bayer Ag Verfahren zur Herstellung von 2-Cycloalkylaminooxazolinen
DE1670752A1 (de) * 1966-09-27 1970-12-23 Bayer Ag Verfahren zur Herstellung von 2-Phenylamino-oxazolinen

Also Published As

Publication number Publication date
GB1453703A (en) 1976-10-27
JPS5335949B2 (de) 1978-09-29
FR2212143A1 (de) 1974-07-26
IL49288A (en) 1977-06-30
JPS5359665A (en) 1978-05-29
US3988464A (en) 1976-10-26
NL7317536A (de) 1974-07-02
CH592641A5 (de) 1977-10-31
HU169273B (de) 1976-10-28
IL49288A0 (en) 1976-05-31
DK145574C (da) 1983-05-30
ES421879A1 (es) 1976-08-01
JPS5422978B2 (de) 1979-08-10
DE2362754A1 (de) 1974-07-11
CS186258B2 (en) 1978-11-30
JPS544955B2 (de) 1979-03-12
AT333272B (de) 1976-11-10
ZA739694B (en) 1975-02-26
SU505348A3 (ru) 1976-02-28
AR207336A1 (es) 1976-09-30
DK145574B (da) 1982-12-13
ATA1089973A (de) 1976-03-15
JPS504084A (de) 1975-01-16
IL43749A (en) 1977-06-30
NL169472B (nl) 1982-02-16
FI59999B (fi) 1981-07-31
FI59999C (fi) 1981-11-10
JPS5356664A (en) 1978-05-23
FR2212143B1 (de) 1977-03-11
CH590253A5 (de) 1977-07-29
AU6340073A (en) 1975-06-12
DD110869A5 (de) 1975-01-12
IL43749A0 (en) 1974-03-14
NL169472C (nl) 1982-07-16
DE2362754C2 (de) 1985-11-21
SU591136A3 (ru) 1978-01-30
AR211914A1 (es) 1978-04-14
BE809179A (fr) 1974-06-27

Similar Documents

Publication Publication Date Title
NO783636L (no) Fremgangsmaate for fremstilling av n-fosfonometyl-glycin
SE398880B (sv) Sett att framstella basiskt substituerade 3-bensoyl-bensofuranderivat
SE386173B (sv) Sett att framstella 2-oxazolinderivat.
BG21028A3 (bg) Метод за получаване на амино-бензимидазоли
SE385893B (sv) Sett att framstella diakylxantin-derivat
SE385707B (sv) Sett att framstella 8,9-didehydro-10-alkoxi-ergolenderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
BG20595A3 (bg) Методл за получаване на n-бензхидрил n-р-хидроксилбензил-пиперазини
BG22816A3 (bg) Метод за получаване на 2-алкиламино-дихидропиридини
SE397190B (sv) Sett att framstella substituerade dibensocykloheptener
SE400078B (sv) Sett att framstella kinazolinonderivat
SE401187B (sv) Sett att framstella deltaŸ4-3-ketosteroid-17-propiolakton
SE400281B (sv) Sett att framstella kinazolinonderivat
SE409458B (sv) Sett att framstella 7-amino-desacetoxi-cefalosporansyra
SE399411B (sv) Sett att framstella titantetrafluorid
BG20570A3 (bg) Метод за получаване на n-(етан-2-ол)-2-метокси-4-ацетамино-5- хлорбензамид
SE403107B (sv) Sett att framstella 6-substituerade 3-etoxi-karbonyl hydrazino-pyridaziner
SE396219B (sv) Sett att framstella pyridyl-piperazinderivat
BG19804A3 (bg) Метод за получаване на 4-или-5-нитроимидазоли
BG20795A3 (bg) Метод за получаване на триазинобензимидазоли
SE404192B (sv) Sett att framstella 3 beta-cykloalkyloxi-16 alfa-cyanopregn-5-en-20-oner
SE391516B (sv) Forfarande for framstellning av bensylaminderivat
SE398644B (sv) Sett att framstella farmaceutiskt aktiva 2,10-diklor-12-metyl-(2h-dibenso(d g))1,3)-dioxocinderivat
SE380801B (sv) Sett att framstella pyronoderivat av rifamyciner
SE403102B (sv) Sett att framstella indan-1-karboxylsyraderivat